Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001683168-20-002904
Filing Date
2020-08-28
Accepted
2020-08-28 17:01:06
Documents
5
Effectiveness Date
2020-08-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS phio_defa14a.htm DEFA14A 16169
2 GRAPHIC image_001.jpg GRAPHIC 96869
3 GRAPHIC image_002.jpg GRAPHIC 51924
4 GRAPHIC image_003.jpg GRAPHIC 82027
5 GRAPHIC image_004.jpg GRAPHIC 45003
  Complete submission text file 0001683168-20-002904.txt   397765
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36304 | Film No.: 201148610
SIC: 2834 Pharmaceutical Preparations